Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Fragasso

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|September 5, 2006
A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failureGabriele Fragasso, Altin Palloshi, Patrizia Puccetti, et al.
The American Journal of Cardiology|April 9, 2016
Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical TherapyMassimo Slavich, Francesco Maranta, Andrea Fumero, et al.
Acta Cardiologica|September 4, 2009
Safety and efficacy of doxazosin as an "add-on" antihypertensive therapy in mild to moderate heart failure patientsRoberto Spoladore, Rosa Roccaforte, Gabriele Fragasso, et al.
Recenti Progressi in Medicina|December 24, 2013
[Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]Ludovica Lauretta, Lorenzo Dagna, Luca Alberti, et al.
The American Journal of Cardiology|March 31, 2004
Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteriesAltin Palloshi, Gabriele Fragasso, PierMarco Piatti, et al.
International Journal of Cardiology|March 15, 2025
Therapeutical approach of tricuspid regurgitation and right heart failureCosmo Godino, Giulia Nemola, Antonio Sisinni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2023
Clinical and functional effects of beta-blocker therapy discontinuation in patients with biventricular heart failureMassimo Slavich, Gianluca Ricchetti, Barbara Demarchi, et al.
The American Journal of Cardiology|April 21, 2010
Comparison of exercise electrocardiography, technetium-99m sestamibi single photon emission computed tomography, and dobutamine and dipyridamole echocardiography for detection of coronary artery disease in hypertensive womenChunzeng Lu, Fei Lu, Gabriele Fragasso, et al.
International Journal of Cardiology|July 19, 2022
Effectiveness and cost-efficacy of diuretics home administration via peripherally inserted central venous catheter in patients with end-stage heart failureCosmo Godino, Andrea Scotti, Alessandra Marengo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximabLorenzo Dagna, Angelo Corti, Silvia Langheim, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|September 5, 2006
A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failureGabriele Fragasso, Altin Palloshi, Patrizia Puccetti, et al.
The American Journal of Cardiology|April 9, 2016
Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical TherapyMassimo Slavich, Francesco Maranta, Andrea Fumero, et al.
Acta Cardiologica|September 4, 2009
Safety and efficacy of doxazosin as an "add-on" antihypertensive therapy in mild to moderate heart failure patientsRoberto Spoladore, Rosa Roccaforte, Gabriele Fragasso, et al.
Recenti Progressi in Medicina|December 24, 2013
[Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]Ludovica Lauretta, Lorenzo Dagna, Luca Alberti, et al.
The American Journal of Cardiology|March 31, 2004
Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteriesAltin Palloshi, Gabriele Fragasso, PierMarco Piatti, et al.
International Journal of Cardiology|March 15, 2025
Therapeutical approach of tricuspid regurgitation and right heart failureCosmo Godino, Giulia Nemola, Antonio Sisinni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2023
Clinical and functional effects of beta-blocker therapy discontinuation in patients with biventricular heart failureMassimo Slavich, Gianluca Ricchetti, Barbara Demarchi, et al.
The American Journal of Cardiology|April 21, 2010
Comparison of exercise electrocardiography, technetium-99m sestamibi single photon emission computed tomography, and dobutamine and dipyridamole echocardiography for detection of coronary artery disease in hypertensive womenChunzeng Lu, Fei Lu, Gabriele Fragasso, et al.
International Journal of Cardiology|July 19, 2022
Effectiveness and cost-efficacy of diuretics home administration via peripherally inserted central venous catheter in patients with end-stage heart failureCosmo Godino, Andrea Scotti, Alessandra Marengo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximabLorenzo Dagna, Angelo Corti, Silvia Langheim, et al.
Pageof 12